Evidence map›Paper›PMID 27187164›Full record

ReviewTopics in magnetic resonance imaging : TMRI2016

Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Francesca V Mertan, Matthew D Greer, Sam Borofsky, Ismail M Kabakus, Maria J Merino, Bradford J Wood, Peter A Pinto, Peter L Choyke, Baris Turkbey

Abstract readReview
In one paragraph

Review in Topics in magnetic resonance imaging : TMRI, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Diagnostic scope ofAmerican journal of nuclear medicine and molecular imaging · 2021
    Article
  18. Article
  19. Accuracy ofAmerican journal of nuclear medicine and molecular imaging · 2020
    Article
  20. Prospective comparison of whole-body MRI andEuropean journal of nuclear medicine and molecular imaging · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francesca V Mertan*Molecular Imaging Program, NCI, NIH, Bethesda, MD †Department of Radiology, George Washington University Hospital, Washington, DC ‡Hacettepe University, School of Medicine, Department of Radiology, Ankara, Turkey §Laboratory of Pathology, NCI ¶Center for Interventional Oncology, NCI and Radiology and Imaging Sciences, Clinical Center ||Urologic Oncology Branch, NCI, NIH, Bethesda, MD.
Matthew D Greer
Sam Borofsky
Ismail M Kabakus
Maria J Merino
Bradford J Wood
Peter A Pinto
Peter L Choyke
Baris Turkbey

Funding

Prostate SectionZIABC011081 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI PINTO, PETER · 2009 to 2025
$15.2M
miRNA profiling of prostate cancer in young and older male patientsZIABC011406 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI MERINO, MARIA · 2011 to 2023
$1.8M
Interventional OncologyZIACL040015 · CLC · CLINICAL CENTER · PI WOOD, BRADFORD · 2009 to 2025
$0k
Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

There is growing consensus that multiparametric magnetic resonance imaging (mpMRI) is an effective modality in the detection of locally recurrent prostate cancer after prostatectomy and radiation therapy. The emergence of magnetic resonance (MR)-guided focal therapies, such as cryoablation, high-intensity focused ultrasound, and laser ablation, have made the use of mpMRI even more important, as the normal anatomy is inevitably altered and the detection of recurrence is made more difficult. The aim of this article is to review the utility of mpMRI in detecting recurrent prostate cancer in patients following radical prostatectomy, radiation therapy, and focal therapy and to discuss expected post-treatment mpMRI findings, the varied appearance of recurrent tumors, and their mimics.

Indexed as

Evidence-Based MedicineHumansMagnetic Resonance ImagingMaleMultimodal ImagingNeoplasm Recurrence, LocalPrognosisProstatic NeoplasmsReproducibility of ResultsSensitivity and SpecificityTreatment Outcome

Identifiers

PMID27187164
PMCPMC5462597

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.